Log In
Print this Print this

bempedoic acid (ETC-1002)

  Manage Alerts
Collapse Summary General Information
Company Esperion Therapeutics Inc.
DescriptionATP citrate lyase (ACLY) inhibitor
Molecular Target ATP citrate lyase (ACLY)
Mechanism of ActionATP citrate lyase (ACLY) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypercholesterolemia
Indication DetailsTreat heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease; Treat hypercholesterolemia; Treat hypercholesterolemia and hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today